ClinicalTrials.Veeva

Menu

Virtual Reality Exposure Therapy Versus Exposure in Vivo for Social Phobia

V

VU University of Amsterdam

Status

Completed

Conditions

Social Phobia
Social Anxiety Disorder

Treatments

Behavioral: Exposure in vivo
Behavioral: Virtual Reality Exposure Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT01746667
05510207

Details and patient eligibility

About

The current study aims at comparing the efficacy of exposure in vivo and exposure via virtual reality for social anxiety disorder. 70 patients with social anxiety disorder will be randomized to either one of the active conditions or to a waiting-list condition. Participants on the waiting-list will be offered either exposure in vivo of in virtual reality after a waiting period of five weeks. Levels of psychopathology will be assessed at pre- and post-treatment as well as three and 12 months after treatment.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 - 65 years old
  • a primary diagnosis of social anxiety disorder as measured with the SCID
  • fluency in Dutch.

Exclusion criteria

  • psychotic episodes in the past, suicidal intentions or substance dependence.
  • behavior therapy in the preceding one year.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

70 participants in 3 patient groups

Exposure in vivo
Experimental group
Description:
This treatment will consist of 10 sessions (twice a week) of exposure therapy based on the protocol used previously in exposure therapy for social anxiety disorder by Scholing \& Emmelkamp (1993).
Treatment:
Behavioral: Exposure in vivo
Virtual Reality Exposure Therapy
Experimental group
Description:
This treatment consists of 10 sessions (twice a week) of exposure therapy by using virtual environments. The difference between the exposure in vivo and virtual reality exposure therapy is the exposure component, which will be delivered in vivo in one condition and through the Head Mounted Display (HMD) in the other condition.
Treatment:
Behavioral: Virtual Reality Exposure Therapy
Wait-list
No Intervention group
Description:
Participants on the wait-list will be offered either exposure in vivo or in virtual reality after a waiting period of five weeks.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems